Skip to content

Clinical trials

Completed Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Status: Completed Clear all

626 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20039
200417
20055
20068
200722
200816
200913
201013
201120
201229
201323
201422
201525
201623
201739
201830
201931
2020131
202141
202226
202326
202418
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed626

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris12
Hospices Civils de Lyon11
University Hospital, Clermont-Ferrand10
University of Minnesota9
National Heart, Lung, and Blood Institute (NHLBI)8
Policlinico Hospital8
Southeast University, China6
University of Zurich6
Ain Shams University5
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome626
COVID-19101
Acute Lung Injury76
Respiratory Insufficiency54
Premature Birth46
Coronavirus Infections28
Sepsis28
Lung Diseases27
Pneumonia27
Bronchopulmonary Dysplasia22

Trials

Showing 1 to 25 of 626. Each trial links to its page on Pharma Observatory.

526 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.